Showing results (591-600 of 2,106) with videos related to
Sort By:
Pageof 211
CNS Drugs|July 24, 2004
Intranasal medications for the treatment of migraine and cluster headacheAlan M Rapoport, Marcelo E Bigal, Stewart J Tepper, et al.CNS Drugs|June 30, 2004
Dose response and atypical antipsychotics in schizophreniaBruce J Kinon, Jonna Ahl, Virginia L Stauffer, et al.CNS Drugs|September 13, 2022
A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic ReviewNiloufar Pouyan, Zahra Halvaei Khankahdani, Farnaz Younesi Sisi, et al.CNS Drugs|October 4, 2022
Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic EncephalopathiesAdam Strzelczyk, Susanne Schubert-BastCNS Drugs|September 7, 2022
Inebilizumab: A Review in Neuromyelitis Optica Spectrum DisorderTina Nie, Hannah A BlairCNS Drugs|March 2, 2021
Targeting β-Arrestins in the Treatment of Psychiatric and Neurological DisordersSharonda S Harris, Nikhil M UrsCNS Drugs|September 26, 2022
Psychotropic Drugs and Adverse Kidney Effects: A Systematic Review of the Past Decade of ResearchJoseph Junior Damba, Katie Bodenstein, Paola Lavin, et al.CNS Drugs|January 10, 2022
Pharmacological Management of Apathy in DementiaLaiba Azhar, Raphael W Kusumo, Giovanni Marotta, et al.CNS Drugs|June 1, 2011
Transdermal rivastigmine: management of cutaneous adverse events and review of the literatureJill Greenspoon, Nathan Herrmann, David N AdamPageof 211